SLC6A4 and Huntington disease: Perhaps, the risk of psychiatric distress in HD patients may be largely modulated by non-genetic factors or epigenetic alterations such as methylation to the promoter region of SLC6A4 which resulted in decreased serotonin synthesis [40, 41].